Effective Communication for Preventing and Responding to Oncology Adverse Events
N/A
21 Years
80 Years
21 Years
80 Years
Open (Enrolling)
Both
Cancer
Both
Cancer
Trial Information
Effective Communication for Preventing and Responding to Oncology Adverse Events
Inclusion Criteria:
- Cancer survivors
- 21 to 80 years of age
- Able to communicate in English
- have adequate hearing
- no cognitive impairments
Exclusion Criteria:
-Any non-melanoma skin cancer, Breast cancer in situ, Cervical intraepithelial neoplasia
(CIN): types I, II, III, Stage I colon cancer, Stage IV cancer, Recurrent cancer or second
primary
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research
Outcome Measure:
Calculate differences in satisfaction with cancer care communication, using a summary score from patient surveys, between intervention and control groups.
Outcome Time Frame:
8 months
Safety Issue:
No
Principal Investigator
Kathleen M Mazor, EdD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Massachusetts, Worcester
Authority:
United States: Institutional Review Board
Study ID:
1184
NCT ID:
NCT01871948
Start Date:
October 2008
Completion Date:
February 2014
Related Keywords:
- Cancer
Name | Location |
|---|---|
| Kaiser Permanente Georgia | Atlanta, Georgia 30300 |
| Group Health | Seattle, Washington 98124 |
